Press Releases Avacta Group Plc

Equities

AVCT

GB00BYYW9G87

Delayed London S.E. Other stock markets 08:42:03 2024-05-15 EDT			5-day change	1st Jan Change
44.35 ^GBX	-0.89%		-0.78%	-61.93%

05-07	AstraZeneca target raised; Antofagasta lowered	AN
05-01	Avacta picks Christina Coughlin to replace long-serving CEO	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avacta Group plc - Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	05-01	AQ
Avacta : Results for the Year Ended 31 December 2023	04-30	PU
Avacta : Preliminary Results for the Year Ended 31 December 2023	04-30	PU
Avacta : Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	04-30	PU
Avacta : R&D Spotlight series – Episode 2	04-25	PU
Avacta Group plc - Block Listing Application to AIM	04-24	AQ
Avacta Group plc - Notice of Results	04-24	AQ
Avacta Therapeutics Reports Data from the Ongoing Phase 1 Clinical Trial of AVA6000 at the AACR Annual Meeting Demonstrating Clinical Proof-of-Concept Showing Multiple Patient Responses	04-10	AQ
Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update	04-05	GL
Avacta : Glossary	04-05	PU
Avacta : Research and Development Spotlight Series – Episode 1	03-27	PU
Avacta Group - Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be presented in a Poster at the American Association of Cancer Research Annual Meeting on April 9, 2024	03-07	AQ
Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024	03-05	AQ
Avacta Group plc - Appointment of Chief Business Officer	12-20	AQ
Appointment of Chief Business Officer	12-19	AQ
Avacta : ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data	12-13	PU
Avacta Group plc - Block Listing Application to AIM	23-10-19	AQ
Avacta to present promising new data from Affimer® and pre\|CISIONTM platform assets at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	23-10-05	AQ
Avacta Group plc - Director, PDMR Shareholdings	23-10-02	AQ
Avacta Group plc - Peel Hunt Appointed as Joint Broker	23-09-21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Avacta Group Plc

Equities

AVCT

GB00BYYW9G87

Press Releases

Filters